KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash & Current Investments (2018 - 2025)

Castle Biosciences' Cash & Current Investments history spans 7 years, with the latest figure at $299.5 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 2.17% year-over-year to $299.5 million; the TTM value through Dec 2025 reached $299.5 million, up 2.17%, while the annual FY2025 figure was $299.5 million, 2.17% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $299.5 million at Castle Biosciences, up from $287.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $407.0 million in Q1 2021 and bottomed at $225.5 million in Q2 2023.
  • The 5-year median for Cash & Current Investments is $275.6 million (2025), against an average of $285.8 million.
  • The largest annual shift saw Cash & Current Investments soared 312.54% in 2021 before it fell 26.76% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $329.6 million in 2021, then decreased by 21.54% to $258.6 million in 2022, then dropped by 6.0% to $243.1 million in 2023, then increased by 20.58% to $293.1 million in 2024, then rose by 2.17% to $299.5 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Cash & Current Investments are $299.5 million (Q4 2025), $287.5 million (Q3 2025), and $275.9 million (Q2 2025).